US Bancorp DE decreased its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 63.7% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,516 shares of the company’s stock after selling 9,680 shares during the period. US Bancorp DE’s holdings in Acadia Healthcare were worth $167,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. UMB Bank n.a. lifted its holdings in shares of Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company’s stock worth $38,000 after buying an additional 755 shares during the period. State of Wyoming purchased a new stake in shares of Acadia Healthcare in the 4th quarter worth $56,000. Aquatic Capital Management LLC purchased a new stake in shares of Acadia Healthcare in the 4th quarter worth $97,000. Sterling Capital Management LLC lifted its holdings in shares of Acadia Healthcare by 59.1% in the 4th quarter. Sterling Capital Management LLC now owns 5,456 shares of the company’s stock worth $216,000 after buying an additional 2,026 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in shares of Acadia Healthcare by 143.8% in the 1st quarter. GAMMA Investing LLC now owns 5,812 shares of the company’s stock worth $176,000 after buying an additional 3,428 shares during the period.
Acadia Healthcare Trading Up 1.5%
Shares of NASDAQ:ACHC opened at $20.98 on Friday. The business’s 50-day moving average is $21.97 and its 200 day moving average is $26.94. Acadia Healthcare Company, Inc. has a 1 year low of $17.13 and a 1 year high of $82.40. The firm has a market capitalization of $1.94 billion, a P/E ratio of 13.89, a P/E/G ratio of 4.08 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32.
Analyst Ratings Changes
Several brokerages have weighed in on ACHC. Royal Bank Of Canada set a $28.00 target price on Acadia Healthcare and gave the stock an “outperform” rating in a report on Wednesday. Guggenheim lowered their target price on Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating for the company in a report on Thursday, August 7th. KeyCorp reduced their price target on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. UBS Group reduced their price target on Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $26.00 price target (down from $40.00) on shares of Acadia Healthcare in a research report on Thursday. Five research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, Acadia Healthcare presently has an average rating of “Moderate Buy” and an average target price of $40.77.
Get Our Latest Stock Analysis on Acadia Healthcare
Acadia Healthcare Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also
- Five stocks we like better than Acadia Healthcare
- ETF Screener: Uses and Step-by-Step Guide
- 3 Energy Stocks to Gain Exposure to the Carbon Capture Boom
- Comparing and Trading High PE Ratio Stocks
- AI Glasses to Replace Smartphones? Meta Is Taking Aim at Apple
- Trading Halts Explained
- The Real Reason Ford Stock Is Rallying—Can It Keep Going?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.